Products for Research Use Only
RegisterLogin

Cibisatamab

CAT: 0804-HY-P99011-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99011-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cibisatamab, a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab can be used for colorectal cancer research[1].
CAS Number
1855925-27-7
UNSPSC
12352203
Target
CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cibisatamab.html
Purity
99.75
Solubility
H2O
Smiles
[Cibisatamab]
Molecular Weight
(171 kDa)
References & Citations
[1]Reyes Gonzalez-Exposito, et al. CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids. J Immunother Cancer. 2019 Apr 15;7 (1) :101.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T76674-01Cibisatamab
GTR18337604-01Cibisatamab Antibody
HY546036-01Research Grade Cibisatamab
E55B1221Cibisatamab (Reference antibody)
591749Cibisatamab (CD3E, CEACAM5)
KBI1231KRIBIOLISA™ Cibisatamab ELISA
ABS-158-1mgCibisatamab Biosimilar, Research Grade
ICH5041-20mgCibisatamab Biosimilar - Research Grade
GTR18697865-01Cibisatamab Human Monoclonal Antibody
B22117301-01Anti-Human CD3xCEACAM5 (Cibisatamab)

Popular Products